CivicaScript announces availability of low-cost insulin and biosimilar for chronic inflammatory conditions in the US
PR Newswire —
New additions expand company's rapidly growing product portfolio LEHI, Utah, Jan. 5, 2026 /PRNewswire/ -- CivicaScript®, LLC, a nonprofit company dedicated to bringing low-cost generic medicines and biosimilars to U.S. patients, today announced the availability of two new products:...